Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia.

Notably, in this model, the introduction of antibodies against TGF-β1 resulted in increased proliferation of primary AML cells; however, this increase did not reach statistical significance in terms of the number of cells treated with cytarabine ( Schelker et al., 2018 ).

also in 111,027 other papers